Immunological models in high dilution research following M Bastide

In 1994, Madeleine Bastide described experimental models in immunology that were used during the 1980s to investigate high dilution effects on several biological systems. She classified the available papers in four categories: High dilutions of antigens; High dilutions of thymus, bursa and other hormones; High dilutions of cytokines; Immunopharmacological activity of silica. The studies about high dilutions of antigens were not continued after this period, but gave rise to a long process of a series of in vitro models on antigens and histamine dilutions, that led to the demonstration of the biological modulation effects of these preparations on basophil degranulation. During this process, a multi-centre study was performed, with a high degree of reproducibility among different independent laboratories.

The studies about high diluted cytokines, thymulin and other hormones opened a new line of scientific investigation, about the regulatory properties of endogenous substances prepared according to homeopathic methods. The most frequently studied substance, thymulin, when administered to mice at 5cH potency, is able to improve the activity of phagocytes in different experimental situations, such as viral, bacterial and parasitic infections. The immunopharmacological activity of silica was demonstrated, at that time, as an in vivo illustration of the homeopathic ‘similia principle’. More recently, studies on silica have assumed another focus: the putative role of silica as active contaminant present in high dilutions. This paper presents a follow-up summary on these items, considering the evolution of discoveries from 1994 to 2014.

Keywords

Immunology - Ultra high dilution - Homeopathy

• References

• 1 Bastide M. Immunological examples on ultra high dilution research. In: Endler P.C., Schulte J. (eds). Ultra High Dilution: Physiology and Physics. 1994. Dordrecht: Kluwer Academic; pp 27-33.
• 2 Shinohara N., Watanabe M., Sachs D.H., Hozumi N. Killing og antigen-reactive B cells class II-restricted soluble antigen-specific CD8⁺ cytolytic T lymphocytes. Nature 1989; 336: 481-484.
• 3 Leung-Tack J., Martinez J., Sansot J.L., Manuel Y., Colle A. Inhibition of phagocyte functions by a synthethic peptide lys-pro-pro-arg (postin). Protides Biol Fluids Proc Colloq 1986; 34: 205-208.
• 4 Weisman Z., Topper R., Oberbaum M., Bentwich Z. Immunomodulation of specific immune response to KLH by high dilution of antigen. Abstract. GIRI meeting, Paris 1992.
• 5 Aabel S., Laerum E., Dølvik S., Djupesland P. Is homeopathic “immunotherapy” effective? A double-blind, placebo-controlled trial with the isopathic remedy Betula 30c for patients with birch pollen allergy. Br Homeopath J 2000; 89 (04) 161-168.
• 6 Aabel S. No beneficial effect of isopathic prophylactic treatment for birch pollen allergy during a low-pollen season: a double-blind, placebo-controlled clinical trial of homeopathic Betula 30c. Br Homeopath J 2000; 89 (04) 169-173.
• 7 Kim L.S., Riedlinger J.E., Baldwin C.M. et al. Treatment of seasonal allergic rhinitis using homeopathic preparation of common allergens in the southwest region of the US: a randomized, controlled clinical trial. Ann Pharmacother 2005; 39 (04) 617-624.
• 8 Ullman D., Frass M. Review of homeopathic research in the treatment of respiratory allergies. Altern Med Rev 2010; 15 (01) 48-58.
• 9 Naidoo P., Pellow J. A randomized placebo-controlled pilot study of cat saliva 9cH and Histaminum 9cH in cat allergic adults. Homeopathy 2013; 102 (02) 123-129.
• 10 Poitevin B., Davenas E., Benveniste J. In vitro immunological degranulation of human basophils is modulated by lung histamine and Apis mellifica . Br J Clin Pharmacol 1988; 25 (04) 439-444.
• 11 Belon P., Cumps J., Ennis M. et al. Histamine dilutions modulate basophil activation. Inflamm Res 2004; 53 (05) 181-188.
• 12 Lorenz I., Schneider E.M., Stolz P., Brack A., Strube J. Influence of the diluent on the effect of highly diluted histamine on basophil activation. Homeopathy 2003; 92 (01) 11-18.
• 13 Chirumbolo S., Brizzi M., Ortolani R., Vella A., Bellavite P. Inhibition of CD203c membrane up-regulation in human basophils by high dilutions of histamine: a controlled replication study. Inflamm Res 2009; 58 (11) 755-764.
• 14 Sainte-Laudy J., Belon P. Inhibition of basophil activation by histamine: a sensitive and reproducible model for the study of the biological activity of high dilutions. Homeopathy 2009; 98 (04) 186-197.
• 15 Bastide M., Doucet-Jaboeuf M., Daurat V. Activity and chronopharmacology of very low doses of physiological immune inducer. Immunol Today 1985; 6: 234-235.
• 16 Bastide M., Daurat V., Doucet-Jaboeuf M., Pélegrin A., Dorfman P. Immunomodulator activity of very low doses of thymulin in mice. Int J Immunother 1987; 3: 191-200.
• 17 Doucet-Jaboeuf M., Guillemain J., Piechaczyk M., Karouby Y., Bastide M. Evaluation de la dose limite d’activité du Facteur Thymique Sérique. C R Seances Acad Sci III 1982; 295: 283-286.
• 18 Doucet-Jaboeuf M., Pélegrin A., Cot M.C., Guillemain J., Bastide M. Seasonal variations in the humoral immune response in mice following administration of thymic hormones. Annu Rev Chronopharmacol 1984; 1: 231-234.
• 19 Guellati M. Les relations immuno-corticotropes: effects de la boursectomie embryonnaire et du traitement substitutif par la boursine. [Thesis] Univeristé du Languedoc.; 1990.
• 20 Youbicier-Simo B.J., Boudard F., Mekaouche M., Bastide M., Baylé J.D. The effects of embryonic bursectomy and in ovo administration of highly diluted bursin on adrenocorticotropic and immune response of chicken. Int J Immunother 1993; 9: 169-180.
• 21 Bonamin L.V., Martinho K.S., Nina A.L., Caviglia F., Do Rio R.G. Very high dilutions of dexamethasone inhibit its pharmacological effects in vivo . Br Homeopath J 2001; 90 (04) 198-203.
• 22 Bonamin L.V., de Moraes C.L., Sanches F. et al. Rats born to mothers treated with dexamethasone 15 cH present changes in modulation of inflammatory process. Evid Based Complement Altern Med 2012; 2012: 710923.
• 23 Sato C., Listar V.G., Bonamin L.V. Development of broiler chickens after treatment with thymulin 5cH: a zoo technical approach. Homeopathy 2012; 101 (01) 68-73.
• 24 Bonamin L.V., Sato C., Zalla Neto R. et al. Immunomodulation of homeopathic thymulin 5CH in a BCG-induced granuloma model. Evid Based Complement Altern Med 2013; 2013: 686018.
• 25 Siqueira C.M., Bonamin L.V., Motta P.D. et al. Evaluation of immune response of Balb/c to homeopathic solutions. Int J High Dilution Res 2012; 11 (40) 152-153.
• 26 Santana F.R., Coelho C.P., Cardoso T.N., Laurenti M.D., Hurtado E.C.P., Bonamin L.V. Modulation of inflammation response to murine cutaneous leishmaniosis by homeopathic medicines: Thymulin 5cH. Homeopathy 2014; 103: 275-284.
• 27 Daurat V., Carrière V., Douylliez C., Bastide M. Immunomodulatory activity of thymulin and a,b interferon on the specific and the non-specific cellular response of C57/BL6 and NZB mice. Immunobiology 1986; 173: 188.
• 28 Daurat V., Sizes M., Doucet-Jaboeuf M., Gillemain J., Bastide M. An immunopharmacological study on very low doses of mediators in mice. 6th International Congress of Immunology, Toronto, Canada 1986.
• 29 Daurat V., Dorfman P., Bastide M. Immunomodulatory activity of low doses of interferon alpha-beta in mice. Biomed Pharmacother 1988; 42: 197-206.
• 30 Carrière V., Bastide M. Influence of mouse age on PMA-induced chemiluminescence of peritoneal cells incubated with a,b interferon at very low and moderate doses. Int J Immunother 1990; 6: 211-214.
• 31 Wagner H., Kreher B., Jurcic K. In vitro stimulation of human granulocytes and lymphocytes by pico- and fentogram quantities of cytostatic agents. Arzneimforschung 1988; 38: 273-275.
• 32 Siqueira C.M., Costa B., Amorim A.M. et al. H3N2 homeopathic influenza virus solution modifies cellular and biochemical aspects of MDCK and J774G8 cell lines. Homeopathy 2013; 102 (01) 31-40.
• 33 Ramachandran C., Nair P.K., Clèment R.T., Melnick S.J. Investigation of cytokine expression in human leukocyte cultures with two immune-modulatory homeopathic preparations. J Altern Complement Med 2007; 13 (04) 403-407.
• 34 Oliveira S.M., de Oliveira C.C., Abud A.P.R. et al. Mercurius solubilis: actions on macrophages. Homeopathy 2011; 100 (04) 228-236.
• 35 Oliveira C.C., Abud A.P., de Oliveira S.M. et al. Developments on drug discovery and on new therapeutics: highly diluted tinctures act as biological response modifiers. BMC Complement Altern Med 2011; 11: 101.
• 36 Cesar B., Abud A.P., Oliveira C.C. et al. Activation of mononuclear boné marrow cells treated in vitro with a complex homeopathic mediation. Micron 2008; 39 (04) 461-470.
• 37 Oliveira C.C., de Oliveira S.M., Godoy L.M., Gabardo J., Buchi D.F. Canova, a Brazilian medical formulation, alters oxidative metabolism of mice macrophages. J Infect 2006; 52 (06) 420-432.
• 38 Oliveira C.C., de Oliveira S.M., Goes V.M., Probst C.M., Krieger M.A., Buchi D.F. Gene expression profiling of macrophages following mice treatment with an immunomodulator medication. J Cell Biochem 2008; 104 (04) 1364-1377.
• 39 Burbano R.R., Leal M.F., da Costa J.B. et al. Lymphocyte proliferation stimulated by activated human macrophages treated with Canova. Homeopathy 2009; 98 (01) 45-48.
• 40 Coelho Moreira C.O., de Fátima Ferreira Borges da Costa J., Leal M.F. et al. Lymphocyte proliferation stimulated by activated Cebus apella macrophages treated with a complex homeopathic immune response modifiers. Homeopathy 2012; 101 (01) 74-79.
• 41 Fimiani V., Cavallaro A., Ainis O., Bottari C. Immunomodulatory effect of the homoeopathic drug Engystol-N on some activities of isolated human leukocytes and in whole blood. Immunopharmacol Immunotoxicol 2000; 22: 103-115.
• 42 Glatthaar-Saalmuller B. In vitro evaluation of the antiviral effects of the homeopathic preparation Gripp-Heel on selected respiratory viruses. Can J Physiol Pharmacol 2007; 85: 1084-1090.
• 43 Saha S., Hossain D.M., Mukherjee S. et al. Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner via an immuno-modulatory circuit. BMC Complement Altern Med 2013; 13: 230.
• 44 Thangapazham R.L., Rajeshkumar N.V., Sharma A. et al. Effect of homeopathic treatment on gene expression in Copenhagen rat tumor tissues. Integr Cancer Ther 2006; 5: 350-355.
• 45 Bellavite P., Conforti A., Pontarollo F., Ortolani R. Immunology and homeopathy: 2. Cells of the immune system and inflammation. Evid Based Complement Altern Med 2006; 3 (01) 13-24.
• 46 Davenas E., Poitevin B., Benveniste J. Effect on mouse peritoneal macrophages of orally administered very high dilutions of silica. Eur J Pharmacol 1987; 135: 313-319.
• 47 Oberbaum M., Markovits R., Weisman Z., Kalinkevits A., Bentwich Z. Wound healing by homeopathic silica dilutions in mice. Harefuah 1992; 123: 79-82.
• 48 Da Rocha Piemonte M., de Freitas Buchi D. Analysis of IL-2, IFN-γ and TNF-α production, α5β1 integrins and actin filaments distribution in peritoneal mouse macrophages treated with homeopathic medicament. J Submicrosc Cytol Pathol 2002; 34 (03) 255-263.
• 49 Ives J.A., Moffett J.R., Arun P. et al. Enzyme stabilization by glass-derived silicates in glass-exposed aqueous solutions. Homeopathy 2010; 99 (01) 15-24.
• 50 Bell I.R., Schwartz G.E., Boyer N.N., Koithan M., Brooks A.J. Advances in integrative nanomedicine for improving infectious disease treatment in public health. Eur J Integr Med 2013; 5 (02) 126-140.
• 51 Demangeat J.L. Nanosized solvent superstructures in ultramolecular aqueous dilutions: twenty years’ research using water proton NMR relaxation. Homeopathy 2013; 102 (02) 87-105.
• 52 Bastide J.M. L’Oeuvre scientifique de Madeleine Bastide, Professeur des Univeristés: homéopathie, nocivité des téléphones portables. Independent Edition 2014. 978-2-84210-276-0 374.
• 53 Bastide M., Lagache A. A communication process: a new paradigm applied to high-dilution effects on the living body. Altern Ther Health Med 1997; 3 (04) 35-39.
• 54 Bonamin L.V., Waisse S. Biology and sign theory: homeopathy emerging as a biosemiotic system. J Med Person 2015; 13 (01) 18-22.
• 55 Mannaioni P.F., Mastroianni R., Mastrangelo D. Adrenaline inhibits the immunological activation of human basophils at pharmacological and ultra-low doses. Med Sci Monit 2010; 16 (07) 227-232.
• 56 Guggisberg A.G., Baumgartner S.M., Tschopp C.M., Heusser P. Replication study concerning the effects of homeopathic dilutions of histamine on human basophil degranulation in vitro . Complement Ther Med 2005; 13 (02) 91-100.
• 57 Wälchli C., Baumgartner S. Flow cytometric analysis of the inhibition of human basophil activation by histamine high dilutions – a replication study. Int J High Dilution Res 2012; 11 (40) 172-173.
• 58 Bonamin L.V. Arnica montana and behavior of connective tissue. In: Bonamin L.V. (ed). Signal and Images, Contributions and Contradictions about High Dilution Research. 2008. Dordrecht: Springer; pp.113-126.
• 59 Kawakami A.P., Sato C., Cardoso T.N., Bonamin L.V. Inflammatory process modulation by homeopathic Arnica montana 6cH: the role of individual variation. Evidence-based Complementary Altern Med 2011; http://dx.doi.org/10.1155/2011/917541.  
• 60 Iannitti T., Morales-Medina J.C., Bellavite P., Rottigni V., Palmieri B. Effectiveness and safety of Arnica montana in post-surgical setting, pain and inflammation. Am J Ther 2014; DOI: [Epub ahead of print].
• 61 Reggiani P.C., Schwerdt J.I., Console G.M., Roggero E.A., Dardenne M., Goya R.G. Physiology and therapeutic potential of the thymic peptide thymulin. Curr Pharm Des 2014; 20 (29) 4690-4696.